Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
FRESENIUS MEDICAL CARE AG & CO. KGAA Fresenius Medical Care AG & Co. KGaA Stock price
Equities
FME
DE0005785802
Healthcare Facilities & Services
|
Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 38.02 EUR | -1.72% | +1.80% | +24.24% | |
| 10:31am | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan reiterates its Sell rating | ZD |
| Dec. 01 | Fresenius Medical Care AG & Co. KGaA will Change its Name to Fresenius Medical Care AG | CI |
| Sales 2023 * | 19.47B 21.11B | Sales 2024 * | 20.2B 21.89B | Capitalization | 11.35B 12.3B |
|---|---|---|---|---|---|
| Net income 2023 * | 441M 478M | Net income 2024 * | 774M 839M | EV / Sales 2023 * | 1,17x |
| Net Debt 2023 * | 11.41B 12.37B | Net Debt 2024 * | 10.74B 11.65B | EV / Sales 2024 * | 1,09x |
| P/E ratio 2023 * | 24,2x | P/E ratio 2024 * | 15,1x | Employees | 123,106 |
| Yield 2023 * | 2,57% | Yield 2024 * | 2,91% | Free-Float | 67.8% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -1.38% | ||
| 1 week | +2.17% | ||
| Current month | +1.30% | ||
| 1 month | +19.12% | ||
| 3 months | -10.52% | ||
| 6 months | -6.80% | ||
| Current year | +24.70% |
1 week
36.81
38.68
1 month
30.9538.68
Current year
28.8249.62
1 year
28.8249.62
3 years
25.9571.14
5 years
25.9581.10
10 years
25.9593.82
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 55 | 2019 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 64 | 2008 |
Dominik Heger
IRC | Investor Relations Contact | - | 2017 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Rolf Classon
BRD | Director/Board Member | 78 | 2011 |
Pascale Witz
BRD | Director/Board Member | 56 | 2016 |
Dorothea Wenzel
BRD | Director/Board Member | 54 | 2019 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | 0.00% | ||
| 7.48% | 119 M€ | 0.00% | - | |
| 6.29% | 84 M€ | +1.10% | ||
| 6.13% | 1,054 M€ | -.--% | ||
| 6.02% | 230 M€ | +4.70% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-05 | 37.98 | -1.81% | 90 580 |
| 23-12-04 | 38.68 | +1.79% | 355,107 |
| 23-12-01 | 38 | +0.98% | 347,777 |
| 23-11-30 | 37.63 | +0.94% | 685,441 |
| 23-11-29 | 37.28 | -0.08% | 401,131 |
Delayed Quote Xetra, December 05, 2023 at 04:32 am EST
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-02-20
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
38.68EUR
Average target price
41.9EUR
Spread / Average Target
+8.32%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +24.70% | 12 281 M $ | |
| -26.52% | 88 127 M $ | |
| +7.16% | 68 826 M $ | |
| +27.83% | 26 312 M $ | |
| -5.72% | 18 848 M $ | |
| -12.11% | 15 459 M $ | |
| -9.84% | 12 206 M $ | |
| -19.33% | 11 365 M $ | |
| +42.75% | 9 737 M $ | |
| -0.80% | 9 540 M $ |
